Abiopharma

🔍 WHALEN THOMAS GERARD (Director)

Company: HEALTHCARE SERVICES GROUP INC (HCSG)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 135 shares of Common Stock at $18.55 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,286.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof. The reporting person made this election in 2025 which applies to Director's fees earned in 2026 in compliance with the Issuer's blackout period guidelines. The number of shares represents the quotient of the amount of such fees divided by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share. Such DSUs will be settled in shares of common stock ninety days following separation of service from the Board. The reporting person may elect a further deferral beyond the Settlement Date pursuant to the rules of Code Section 409A.
• F2: Amount represents 2,806 unvested DSUs and 480 vested DSUs.